Founded by some of the world's most renowned specialists in cancer diagnosis, treatment and research, Champions Oncology (OCTBB:CSBR) is engaged in the development of advanced technologies to enhance the personalized treatment of human cancers. Based on the proprietary Champions Personalized TumorGraft™ technology, Champions offers cancer patients and their physicians—as well as cancer researchers—powerful tools to more effectively guide cancer treatments for patients and the development of new cancer drugs.
Download XBRL files:
Please contact Susan Foreman at Champions Oncology, Inc., for investor information or to arrange to communicate with Company principals..
- Download an MP3 recording of the FY2014 Q1 Earnings Call.
- Download an MP3 recording of the FY2013 Q4 Earnings Call.
- Download an MP3 recording of the FY2013 Q3 Earnings Call.